Evidence map›Paper›PMID 14593428›Full record

SynthesisMolecular psychiatry2003

Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia.

S J Glatt, S V Faraone, M T Tsuang

Abstract readMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Molecular psychiatry, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 4 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 4 syntheses or guidelines pooled it, 127 citations in OpenAlex.

  1. The brain-derived neurotrophic-factor (BDNF) val66met polymorphism is associated with geriatric depression: a meta-analysis.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2012
    Pooled it
  2. Pooled it
  3. The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: evidence from fixed- and random-effects meta-analyses.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2006
    Pooled it
  4. Meta-analysis in psychiatric genetics.Current psychiatry reports · 2005
    Pooled it
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

S J GlattDepartment of Psychiatry, Harvard Medical School at Massachusetts Mental Health Center, Boston, MA 02115, USA.
S V Faraone
M T Tsuang
Boston University · USMassachusetts General Hospital · USMassachusetts Mental Health Center · US

Funding

SCHIZOPHRENIA--PSYCHOPATHOLOGY AND HETEROGENEITYR01MH043518 · NIMH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI SEIDMAN, LARRY J · 1998 to 2004
$1.8M
GENETIC LINKAGE STUDY OF SCHIZOPHRENIAR01MH059624 · NIMH · MASSACHUSETTS MENTAL HEALTH INSTITUTE · PI TSUANG, MING T. · 1998 to 2001
$1.2M
TRAINING IN PSYCHIATRIC GENETICSR25MH060485 · NIMH · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI BUKA, STEPHEN L · 1999 to 2003
$683k
NIMH NIH HHS R01MH43518NIMH NIH HHS R01MH59624NIMH NIH HHS R01MH60485NIMH NIH HHS R25MH60485
6 · The paper itself

Abstract

The D2 subtype of dopamine receptor has been widely implicated in the pathogenesis of schizophrenia. Early evidence supporting an association between the Cys311Ser polymorphism of the D2 receptor gene (DRD2) and schizophrenia was subsequently refuted and, eventually, dismissed. From all 24 published case-control studies, we calculated a pooled estimate of this association. The pooled odds ratio was 1.3 for the Cys allele, which was highly significant (P=0.007). The odds ratio derived from each study was unrelated to the ethnicity or gender composition of the sample, or the age of the control group. There was no evidence of publication bias or excessive influence attributable to any given study. Although more family-based studies are needed to confirm this relation, our results provide strong evidence that DRD2 influences susceptibility to schizophrenia.

Indexed as

Polymorphism, GeneticGenetic Predisposition to DiseaseHumansReceptors, Dopamine D2Risk FactorsSchizophreniaReceptors, Dopamine D2

Identifiers

PMID14593428
OpenAlexW2009999409

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.